Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy PerkinElmer stock in Canada | $138.96
Own PerkinElmer shares in just a few minutes.
PerkinElmer is a diagnostics & research business based in the US. PerkinElmer stocks (PKI.US) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $138.96 – a decrease of 4.21% over the previous week. PerkinElmer employs 14,000 staff and has a trailing 12-month revenue of around $4.4 billion.
How to buy PerkinElmer stock in Canada
- Choose a platform. If you're a beginner, our stock trading table below can help you choose.
- Open your account. You'll need your ID, bank details and national insurance number.
- Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
- Search the platform for stock code: PKI in this case.
- Research PerkinElmer stocks. The platform should provide the latest information available.
- Buy your PerkinElmer stocks. It's that simple.
What's in this guide?
- Can I buy shares in PerkinElmer?
- Has coronavirus impacted PerkinElmer shares?
- PerkinElmer shares summary
- Compare share dealing platforms
- Is PerkinElmer stock a buy or sell?
- PerkinElmer performance over time
- Can I short PerkinElmer shares?
- Is PerkinElmer suitable for ethical investing?
- Are PerkinElmer shares over-valued?
- PerkinElmer's financials
- How volatile are PerkinElmer shares?
- Does PerkinElmer pay a dividend?
- Have PerkinElmer shares ever split?
- Other common questions
How has Coronavirus impacted PerkinElmer's stock price?
Since the stock market crash in March caused by coronavirus, PerkinElmer's stock price has had significant positive movement.
Its last market close was $138.96, which is 33.18% up on its pre-crash value of $92.85 and 120.89% up on the lowest point reached during the March crash when the stocks fell as low as $62.91.
If you had bought $1,000 worth of PerkinElmer stocks at the start of February 2020, those stocks would have been worth $730.74 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $1,496.60.
PerkinElmer stock priceUse our graph to track the performance of PKI stocks over time.
PerkinElmer stocks at a glance
|Latest market close||$138.96|
|52-week range||$92.7267 - $162.539|
|50-day moving average||$138.8737|
|200-day moving average||$138.2821|
|Wall St. target price||$158.5|
|Dividend yield||$0.28 (0.2%)|
|Earnings per share (TTM)||$9.564|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy PerkinElmer stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
PerkinElmer price performance over time
|1 month (2021-05-14)||-3.20%|
|3 months (2021-03-16)||10.32%|
|6 months (2020-12-16)||-1.31%|
|1 year (2020-06-16)||40.53%|
|2 years (2019-06-14)||49.52%|
|3 years (2018-06-15)||78.52%|
|5 years (2016-06-16)||163.53%|
Is PerkinElmer under- or over-valued?
Valuing PerkinElmer stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of PerkinElmer's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
PerkinElmer's P/E ratio
PerkinElmer's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 15x. In other words, PerkinElmer stocks trade at around 15x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the stocks or simply that they're under-valued.
PerkinElmer's PEG ratio
PerkinElmer's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.7545. A low ratio can be interpreted as meaning the stocks offer better value, while a higher ratio can be interpreted as meaning the stocks offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into PerkinElmer's future profitability. By accounting for growth, it could also help you if you're comparing the stock prices of multiple high-growth companies.
PerkinElmer's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$1.7 billion.
The EBITDA is a measure of a PerkinElmer's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||USD$4.4 billion|
|Operating margin TTM||32.04%|
|Gross profit TTM||USD$2.1 billion|
|Return on assets TTM||11.73%|
|Return on equity TTM||31.76%|
|Market capitalisation||USD$16.4 billion|
TTM: trailing 12 months
How to short and sell PerkinElmer stocks
- Create a CFD or spread betting account.
- Search for the stock code. E.g. "PKI.US"
- Choose your position size.
- Select "sell" rather than "buy".
- Confirm your position and keep tabs on it. You may wish to set limits on your position.
There are currently 4.5 million PerkinElmer stocks held short by investors – that's known as PerkinElmer's "short interest". This figure is 12.7% up from 4.0 million last month.
There are a few different ways that this level of interest in shorting PerkinElmer stocks can be evaluated.
PerkinElmer's "short interest ratio" (SIR)
PerkinElmer's "short interest ratio" (SIR) is the quantity of PerkinElmer stocks currently shorted divided by the average quantity of PerkinElmer stocks traded daily (recently around 932319.13580247). PerkinElmer's SIR currently stands at 4.86. In other words for every 100,000 PerkinElmer stocks traded daily on the market, roughly 4860 stocks are currently held short.
However PerkinElmer's short interest can also be evaluated against the total number of PerkinElmer stocks, or, against the total number of tradable PerkinElmer stocks (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case PerkinElmer's short interest could be expressed as 0.04% of the outstanding stocks (for every 100,000 PerkinElmer stocks in existence, roughly 40 stocks are currently held short) or 0.0518% of the tradable stocks (for every 100,000 tradable PerkinElmer stocks, roughly 52 stocks are currently held short).
Such a low SIR usually points to an optimistic outlook for the stock price, with fewer people currently willing to bet against PerkinElmer.
Find out more about how you can short PerkinElmer stock.
PerkinElmer's environmental, social and governance track record
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like PerkinElmer.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
PerkinElmer's total ESG risk score
Total ESG risk: 21.66
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and PerkinElmer's overall score of 21.66 (as at 01/01/2019) is pretty good – landing it in it in the 25th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like PerkinElmer is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
PerkinElmer's environmental score
Environmental score: 3.15/100
PerkinElmer's environmental score of 3.15 puts it squarely in the 4th percentile of companies rated in the same sector. This could suggest that PerkinElmer is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
PerkinElmer's social score
Social score: 12.09/100
PerkinElmer's social score of 12.09 puts it squarely in the 4th percentile of companies rated in the same sector. This could suggest that PerkinElmer is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
PerkinElmer's governance score
Governance score: 9.42/100
PerkinElmer's governance score puts it squarely in the 4th percentile of companies rated in the same sector. That could suggest that PerkinElmer is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
PerkinElmer's controversy score
Controversy score: 2/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. PerkinElmer scored a 2 out of 5 for controversy – the second-highest score possible, reflecting that PerkinElmer has, for the most part, managed to keep its nose clean.
Environmental, social, and governance (ESG) summary
|Total ESG score||21.66|
|Total ESG percentile||24.92|
|Environmental score percentile||4|
|Social score percentile||4|
|Governance score percentile||4|
|Level of controversy||2|
PerkinElmer stock dividends
Dividend payout ratio: 3.02% of net profits
Recently PerkinElmer has paid out, on average, around 3.02% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.2% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), PerkinElmer shareholders could enjoy a 0.2% return on their shares, in the form of dividend payments. In PerkinElmer's case, that would currently equate to about $0.28 per share.
While PerkinElmer's payout ratio might seem low, this can signify that PerkinElmer is investing more in its future growth.
PerkinElmer's most recent dividend payout was on 6 August 2021. The latest dividend was paid out to all shareholders who bought their stocks by 15 July 2021 (the "ex-dividend date").
Have PerkinElmer stocks ever split?
PerkinElmer stocks were split on a 2:1 basis on 4 June 2001. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your PerkinElmer stocks – just the quantity. However, indirectly, the new 50% lower stock price could have impacted the market appetite for PerkinElmer stocks which in turn could have impacted PerkinElmer's stock price.
PerkinElmer stock price volatility
Over the last 12 months, PerkinElmer's stocks have ranged in value from as little as $92.7267 up to $162.539. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a stocks volatility in relation to the market. The market (NYSE average) beta is 1, while PerkinElmer's is 1.1082. This would suggest that PerkinElmer's stocks are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. The company operates in two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detection and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as laboratory services. It also provides analytical technologies, solutions, and services for the environmental, food, and industrial markets that enable its customers to understand the characterization and health of various aspects, including air, water, and soil. In addition, this segment offers solutions to farmers and food producers; and analytical instrumentation for the industrial market, which includes the chemical, semiconductor and electronics, energy, lubricant, petrochemical, and polymer industries. The Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology and drug discovery. The company serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. PerkinElmer, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.
Frequently asked questions
More on investing
Find out about 4 ways to invest in this popular crop including futures, futures options, ETFs and stocks.Read more…
Find out about silver ETFs, how they’re traded and where you can buy them in Canada.Read more…
Find out about gold ETFs, what influences their prices, how you can trade them and whether they could be worth your weight in gold.Read more…
More guides on Finder
How to buy Zillow Group stock in Canada | $114.49
Steps to owning and managing Z, with 24-hour and historical pricing before you buy.
How to buy Rigel Pharmaceuticals stock in Canada | $3.72
Steps to owning and managing RIGL, with 24-hour and historical pricing before you buy.
How to buy Ionis Pharmaceuticals stock in Canada | $37.25
Steps to owning and managing IONS, with 24-hour and historical pricing before you buy.
How to buy Forrester Research stock in Canada | $42.91
Steps to owning and managing FORR, with 24-hour and historical pricing before you buy.
How to buy Credit Acceptance Corporation stock in Canada | $447.46
Steps to owning and managing CACC, with 24-hour and historical pricing before you buy.
How to buy Watts Water Technologies stock in Canada | $135.6
Steps to owning and managing WTS, with 24-hour and historical pricing before you buy.
How to buy State Street Corporation stock in Canada | $86.06
Steps to owning and managing STT, with 24-hour and historical pricing before you buy.
How to buy Reata Pharmaceuticals stock in Canada | $136.74
Steps to owning and managing RETA, with 24-hour and historical pricing before you buy.
How to buy R1 RCM stock in Canada | $23.15
Steps to owning and managing RCM, with 24-hour and historical pricing before you buy.
How to buy TitanSwap (TITAN) in Canada
This guide will show you step-by-step instructions on how to buy the TitanSwap (TITAN) token as well as a list of exchanges you can trade it on.
Ask an Expert
You must be logged in to post a comment.